<VariationArchive VariationID="3243728" VariationName="NC_000023.10:g.(?_152954030)_(154005142_?)del" VariationType="Deletion" Accession="VCV003243728" Version="1" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3406188" VariationID="3243728">
      <GeneList>
        <Gene Symbol="GAB3" FullName="GRB2 associated binding protein 3" GeneID="139716" HGNC_ID="HGNC:17515" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154675249" stop="154751566" display_start="154675249" display_stop="154751566" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153903525" stop="153979347" display_start="153903525" display_stop="153979347" Strand="-" />
          </Location>
          <OMIM>300482</OMIM>
        </Gene>
        <Gene Symbol="GDI1" FullName="GDP dissociation inhibitor 1" GeneID="2664" HGNC_ID="HGNC:4226" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154437154" stop="154443467" display_start="154437154" display_stop="154443467" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153665258" stop="153671813" display_start="153665258" display_stop="153671813" Strand="+" />
          </Location>
          <OMIM>300104</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GDI1">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GDI1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="HCFC1" FullName="host cell factor C1" GeneID="3054" HGNC_ID="HGNC:4839" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153947557" stop="153971818" display_start="153947557" display_stop="153971818" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153213007" stop="153236818" display_start="153213007" display_stop="153236818" Strand="-" />
          </Location>
          <OMIM>300019</OMIM>
        </Gene>
        <Gene Symbol="IDH3G" FullName="isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma" GeneID="3421" HGNC_ID="HGNC:5386" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153785768" stop="153794375" display_start="153785768" display_stop="153794375" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153051220" stop="153059977" display_start="153051220" display_stop="153059977" Strand="-" />
          </Location>
          <OMIM>300089</OMIM>
        </Gene>
        <Gene Symbol="IKBKG" FullName="inhibitor of nuclear factor kappa B kinase regulatory subunit gamma" GeneID="8517" HGNC_ID="HGNC:5961" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154541238" stop="154565046" display_start="154541238" display_stop="154565046" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153770458" stop="153793260" display_start="153770458" display_stop="153793260" Strand="+" />
          </Location>
          <OMIM>300248</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="IRAK1" FullName="interleukin 1 receptor associated kinase 1" GeneID="3654" HGNC_ID="HGNC:6112" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154010507" stop="154019902" display_start="154010507" display_stop="154019902" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153275956" stop="153285341" display_start="153275956" display_stop="153285341" Strand="-" />
          </Location>
          <OMIM>300283</OMIM>
        </Gene>
        <Gene Symbol="L1CAM" FullName="L1 cell adhesion molecule" GeneID="3897" HGNC_ID="HGNC:6470" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153861514" stop="153886173" display_start="153861514" display_stop="153886173" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153126970" stop="153141398" display_start="153126970" display_stop="153141398" Strand="-" />
          </Location>
          <OMIM>308840</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=L1CAM">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=L1CAM">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LAGE3" FullName="L antigen family member 3" GeneID="8270" HGNC_ID="HGNC:26058" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154477775" stop="154479281" display_start="154477775" display_stop="154479281" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153705240" stop="153707595" display_start="153705240" display_stop="153707595" Strand="-" />
          </Location>
          <OMIM>300060</OMIM>
        </Gene>
        <Gene Symbol="MECP2" FullName="methyl-CpG binding protein 2" GeneID="4204" HGNC_ID="HGNC:6990" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154021573" stop="154097717" display_start="154021573" display_stop="154097717" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153287263" stop="153363187" display_start="153287263" display_stop="153363187" Strand="-" />
          </Location>
          <OMIM>300005</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="NAA10" FullName="N-alpha-acetyltransferase 10, NatA catalytic subunit" GeneID="8260" HGNC_ID="HGNC:18704" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153929225" stop="153935037" display_start="153929225" display_stop="153935037" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153195279" stop="153200606" display_start="153195279" display_stop="153200606" Strand="-" />
          </Location>
          <OMIM>300013</OMIM>
          <Haploinsufficiency last_evaluated="2022-08-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NAA10">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-08-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NAA10">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="OPN1LW" FullName="opsin 1, long wave sensitive" GeneID="5956" HGNC_ID="HGNC:9936" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154144243" stop="154159032" display_start="154144243" display_stop="154159032" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153409724" stop="153424506" display_start="153409724" display_stop="153424506" Strand="+" />
          </Location>
          <OMIM>300822</OMIM>
        </Gene>
        <Gene Symbol="OPN1MW" FullName="opsin 1, medium wave sensitive" GeneID="2652" HGNC_ID="HGNC:4206" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154182596" stop="154196861" display_start="154182596" display_stop="154196861" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153448084" stop="153462351" display_start="153448084" display_stop="153462351" Strand="+" />
          </Location>
          <OMIM>300821</OMIM>
        </Gene>
        <Gene Symbol="OPN1MW2" FullName="opsin 1, medium wave sensitive 2" GeneID="728458" HGNC_ID="HGNC:26952" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154219756" stop="154233286" display_start="154219756" display_stop="154233286" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153485202" stop="153498754" display_start="153485202" display_stop="153498754" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PDZD4" FullName="PDZ domain containing 4" GeneID="57595" HGNC_ID="HGNC:21167" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153802166" stop="153830544" display_start="153802166" display_stop="153830544" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153067622" stop="153096002" display_start="153067622" display_stop="153096002" Strand="-" />
          </Location>
          <OMIM>300634</OMIM>
        </Gene>
        <Gene Symbol="PLXNA3" FullName="plexin A3" GeneID="55558" HGNC_ID="HGNC:9101" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154458281" stop="154477779" display_start="154458281" display_stop="154477779" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153686622" stop="153701984" display_start="153686622" display_stop="153701984" Strand="+" />
          </Location>
          <OMIM>300022</OMIM>
        </Gene>
        <Gene Symbol="PLXNB3" FullName="plexin B3" GeneID="5365" HGNC_ID="HGNC:9105" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153764249" stop="153779341" display_start="153764249" display_stop="153779341" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153029650" stop="153044800" display_start="153029650" display_stop="153044800" Strand="+" />
          </Location>
          <OMIM>300214</OMIM>
        </Gene>
        <Gene Symbol="RENBP" FullName="renin binding protein" GeneID="5973" HGNC_ID="HGNC:9959" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153935269" stop="153944643" display_start="153935269" display_stop="153944643" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153200721" stop="153210231" display_start="153200721" display_stop="153210231" Strand="-" />
          </Location>
          <OMIM>312420</OMIM>
        </Gene>
        <Gene Symbol="RPL10" FullName="ribosomal protein L10" GeneID="6134" HGNC_ID="HGNC:10298" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154398065" stop="154402339" display_start="154398065" display_stop="154402339" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153626570" stop="153630679" display_start="153626570" display_stop="153630679" Strand="+" />
          </Location>
          <OMIM>312173</OMIM>
          <Haploinsufficiency last_evaluated="2018-10-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPL10">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-10-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPL10">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SLC10A3" FullName="solute carrier family 10 member 3" GeneID="8273" HGNC_ID="HGNC:22979" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154487311" stop="154490629" display_start="154487311" display_stop="154490629" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153715649" stop="153719001" display_start="153715649" display_stop="153719001" Strand="-" />
          </Location>
          <OMIM>312090</OMIM>
        </Gene>
        <Gene Symbol="SLC6A8" FullName="solute carrier family 6 member 8" GeneID="6535" HGNC_ID="HGNC:11055" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153687926" stop="153696593" display_start="153687926" display_stop="153696593" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152953751" stop="152962047" display_start="152953751" display_stop="152962047" Strand="+" />
          </Location>
          <OMIM>300036</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A8">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A8">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SRPK3" FullName="SRSF protein kinase 3" GeneID="26576" HGNC_ID="HGNC:11402" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153781041" stop="153785730" display_start="153781041" display_stop="153785730" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153046455" stop="153051186" display_start="153046455" display_stop="153051186" Strand="+" />
          </Location>
          <OMIM>301002</OMIM>
        </Gene>
        <Gene Symbol="SSR4" FullName="signal sequence receptor subunit 4" GeneID="6748" HGNC_ID="HGNC:11326" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153794159" stop="153798512" display_start="153794159" display_stop="153798512" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153059629" stop="153063966" display_start="153059629" display_stop="153063966" Strand="+" />
          </Location>
          <OMIM>300090</OMIM>
        </Gene>
        <Gene Symbol="TAFAZZIN" FullName="tafazzin, phospholipid-lysophospholipid transacylase" GeneID="6901" HGNC_ID="HGNC:11577" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154411539" stop="154421726" display_start="154411539" display_stop="154421726" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153639876" stop="153650064" display_start="153639876" display_stop="153650064" Strand="+" />
          </Location>
          <OMIM>300394</OMIM>
        </Gene>
        <Gene Symbol="TEX28" FullName="testis expressed 28" GeneID="1527" HGNC_ID="HGNC:2563" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154271265" stop="154295211" display_start="154271265" display_stop="154295211" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153498929" stop="153523563" display_start="153498929" display_stop="153523563" Strand="-" />
          </Location>
          <OMIM>300092</OMIM>
        </Gene>
        <Gene Symbol="TKTL1" FullName="transketolase like 1" GeneID="8277" HGNC_ID="HGNC:11835" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154295795" stop="154330350" display_start="154295795" display_stop="154330350" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153524026" stop="153558712" display_start="153524026" display_stop="153558712" Strand="+" />
          </Location>
          <OMIM>300044</OMIM>
        </Gene>
        <Gene Symbol="TMEM187" FullName="transmembrane protein 187" GeneID="8269" HGNC_ID="HGNC:13705" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153972754" stop="153983194" display_start="153972754" display_stop="153983194" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153237990" stop="153248645" display_start="153237990" display_stop="153248645" Strand="+" />
          </Location>
          <OMIM>300059</OMIM>
        </Gene>
        <Gene Symbol="UBL4A" FullName="ubiquitin like 4A" GeneID="8266" HGNC_ID="HGNC:12505" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154483717" stop="154486615" display_start="154483717" display_stop="154486615" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153712055" stop="153714931" display_start="153712055" display_stop="153714931" Strand="-" />
          </Location>
          <OMIM>312070</OMIM>
        </Gene>
        <Gene Symbol="ABCD1" FullName="ATP binding cassette subfamily D member 1" GeneID="215" HGNC_ID="HGNC:61" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153724856" stop="153744755" display_start="153724856" display_stop="153744755" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152990322" stop="153010215" display_start="152990322" display_stop="153010215" Strand="+" />
          </Location>
          <OMIM>300371</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ABCD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ABCD1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="ARHGAP4" FullName="Rho GTPase activating protein 4" GeneID="393" HGNC_ID="HGNC:674" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153907378" stop="153926264" display_start="153907378" display_stop="153926264" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153172829" stop="153191713" display_start="153172829" display_stop="153191713" Strand="-" />
          </Location>
          <OMIM>300023</OMIM>
        </Gene>
        <Gene Symbol="ATP6AP1" FullName="ATPase H+ transporting accessory protein 1" GeneID="537" HGNC_ID="HGNC:868" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154428677" stop="154436516" display_start="154428677" display_stop="154436516" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153656977" stop="153664861" display_start="153656977" display_stop="153664861" Strand="+" />
          </Location>
          <OMIM>300197</OMIM>
        </Gene>
        <Gene Symbol="AVPR2" FullName="arginine vasopressin receptor 2" GeneID="554" HGNC_ID="HGNC:897" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153902625" stop="153907166" display_start="153902625" display_stop="153907166" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153167984" stop="153172619" display_start="153167984" display_stop="153172619" Strand="+" />
          </Location>
          <OMIM>300538</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-01" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AVPR2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-01" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AVPR2">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="BCAP31" FullName="B cell receptor associated protein 31" GeneID="10134" HGNC_ID="HGNC:16695" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153700492" stop="153724387" display_start="153700492" display_stop="153724387" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152965946" stop="152990200" display_start="152965946" display_stop="152990200" Strand="-" />
          </Location>
          <OMIM>300398</OMIM>
          <Haploinsufficiency last_evaluated="2023-08-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BCAP31">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-08-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BCAP31">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="CTAG1A" FullName="cancer/testis antigen 1A" GeneID="246100" HGNC_ID="HGNC:24198" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154585133" stop="154586816" display_start="154585133" display_stop="154586816" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153813417" stop="153815074" display_start="153813417" display_stop="153815074" Strand="+" />
          </Location>
          <OMIM>300657</OMIM>
        </Gene>
        <Gene Symbol="CTAG1B" FullName="cancer/testis antigen 1B" GeneID="1485" HGNC_ID="HGNC:2491" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154617609" stop="154619282" display_start="154617609" display_stop="154619282" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153845864" stop="153847521" display_start="153845864" display_stop="153847521" Strand="-" />
          </Location>
          <OMIM>300156</OMIM>
        </Gene>
        <Gene Symbol="CTAG2" FullName="cancer/testis antigen 2" GeneID="30848" HGNC_ID="HGNC:2492" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154651977" stop="154653579" display_start="154651977" display_stop="154653579" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153880245" stop="153881852" display_start="153880245" display_stop="153881852" Strand="-" />
          </Location>
          <OMIM>300396</OMIM>
        </Gene>
        <Gene Symbol="DKC1" FullName="dyskerin pseudouridine synthase 1" GeneID="1736" HGNC_ID="HGNC:2890" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154762864" stop="154777689" display_start="154762864" display_stop="154777689" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153991030" stop="154005963" display_start="153991030" display_stop="154005963" Strand="+" />
          </Location>
          <OMIM>300126</OMIM>
          <Haploinsufficiency last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DKC1">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DKC1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="DNASE1L1" FullName="deoxyribonuclease 1 like 1" GeneID="1774" HGNC_ID="HGNC:2957" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154401236" stop="154412101" display_start="154401236" display_stop="154412101" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153629578" stop="153640426" display_start="153629578" display_stop="153640426" Strand="-" />
          </Location>
          <OMIM>300081</OMIM>
        </Gene>
        <Gene Symbol="EMD" FullName="emerin" GeneID="2010" HGNC_ID="HGNC:3331" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154379295" stop="154381523" display_start="154379295" display_stop="154381523" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153607596" stop="153609882" display_start="153607596" display_stop="153609882" Strand="+" />
          </Location>
          <OMIM>300384</OMIM>
        </Gene>
        <Gene Symbol="FAM3A" FullName="FAM3 metabolism regulating signaling molecule A" GeneID="60343" HGNC_ID="HGNC:13749" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154506171" stop="154516232" display_start="154506171" display_stop="154516232" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153733322" stop="153744565" display_start="153733322" display_stop="153744565" Strand="-" />
          </Location>
          <OMIM>300492</OMIM>
        </Gene>
        <Gene Symbol="FAM50A" FullName="family with sequence similarity 50 member A" GeneID="9130" HGNC_ID="HGNC:18786" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154444141" stop="154450654" display_start="154444141" display_stop="154450654" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153672472" stop="153679001" display_start="153672472" display_stop="153679001" Strand="+" />
          </Location>
          <OMIM>300453</OMIM>
        </Gene>
        <Gene Symbol="FLNA" FullName="filamin A" GeneID="2316" HGNC_ID="HGNC:3754" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154348531" stop="154374634" display_start="154348531" display_stop="154374634" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153576899" stop="153603005" display_start="153576899" display_stop="153603005" Strand="-" />
          </Location>
          <OMIM>300017</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLNA">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLNA">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="G6PD" FullName="glucose-6-phosphate dehydrogenase" GeneID="2539" HGNC_ID="HGNC:4057" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154531390" stop="154547569" display_start="154531390" display_stop="154547569" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153759605" stop="153775786" display_start="153759605" display_stop="153775786" Strand="-" />
          </Location>
          <OMIM>305900</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(?_152954030)_(154005142_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="152954030" innerStop="154005142" display_start="152954030" display_stop="154005142" variantLength="1051113" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_152954030)_(154005142_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_152954030)_(154005142_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(?_152954030)_(154005142_?)del AND Creatine transporter deficiency" Accession="RCV004582962" Version="1">
        <ClassifiedConditionList TraitSetID="3187">
          <ClassifiedCondition DB="MedGen" ID="C1845862">Creatine transporter deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.10:g.(?_152954030)_(154005142_?)del AND Dyskeratosis congenita" Accession="RCV004582964" Version="1">
        <ClassifiedConditionList TraitSetID="8154">
          <ClassifiedCondition DB="MedGen" ID="C0265965">Dyskeratosis congenita</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.10:g.(?_152954030)_(154005142_?)del AND Spastic paraplegia" Accession="RCV004582965" Version="1">
        <ClassifiedConditionList TraitSetID="20865">
          <ClassifiedCondition DB="MedGen" ID="C0037772">Spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.10:g.(?_152954030)_(154005142_?)del AND Anemia, nonspherocytic hemolytic, due to G6PD deficiency" Accession="RCV004582959" Version="1">
        <ClassifiedConditionList TraitSetID="2927">
          <ClassifiedCondition DB="MedGen" ID="C2720289">Anemia, nonspherocytic hemolytic, due to G6PD deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.10:g.(?_152954030)_(154005142_?)del AND 3-Methylglutaconic aciduria type 2" Accession="RCV004582960" Version="1">
        <ClassifiedConditionList TraitSetID="3071">
          <ClassifiedCondition DB="MedGen" ID="C0574083">3-Methylglutaconic aciduria type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.10:g.(?_152954030)_(154005142_?)del AND Adrenoleukodystrophy" Accession="RCV004582961" Version="1">
        <ClassifiedConditionList TraitSetID="3100">
          <ClassifiedCondition DB="MedGen" ID="C0162309">Adrenoleukodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.10:g.(?_152954030)_(154005142_?)del AND X-linked Emery-Dreifuss muscular dystrophy" Accession="RCV004582963" Version="1">
        <ClassifiedConditionList TraitSetID="6541">
          <ClassifiedCondition DB="MedGen" ID="C0751337">X-linked Emery-Dreifuss muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-21" NumberOfSubmissions="7" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10480214</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11379875</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11748843</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11968085</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16427346</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16601897</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18177777</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18627054</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19396829</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19846429</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22281021</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22382802</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23409742</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23660394</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24365856</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24962355</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35384376</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9384614</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3100" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="139" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ADDISON DISEASE AND CEREBRAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRONZE SCHILDER DISEASE</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MELANODERMIC LEUKODYSTROPHY</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SIEMERLING-CREUTZFELDT DISEASE</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Adrenoleukodystrophy</ElementValue>
                <XRef ID="Adrenoleukodystrophy/242" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018544" DB="MONDO" />
                <XRef ID="65389002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">X-ALD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ALD</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">Adrenoleukodystrophy, ID</ElementValue>
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">X-linked adrenoleukodystrophy (X-ALD) affects the nervous system white matter and the adrenal cortex. Three main phenotypes are seen in affected males: The childhood cerebral form manifests most commonly between ages four and eight years. It initially resembles attention-deficit disorder or hyperactivity; progressive impairment of cognition, behavior, vision, hearing, and motor function follow the initial symptoms and often lead to total disability within six months to two years. Most individuals have impaired adrenocortical function at the time that neurologic disturbances are first noted. Adrenomyeloneuropathy (AMN) manifests most commonly in an individual in his twenties or middle age as progressive stiffness and weakness of the legs, sphincter disturbances, sexual dysfunction, and often, impaired adrenocortical function; all symptoms are progressive over decades. "Addison disease only" presents with primary adrenocortical insufficiency between age two years and adulthood and most commonly by age 7.5 years, without evidence of neurologic abnormality; however, some degree of neurologic disability (most commonly AMN) usually develops by middle age. More than 20% of female carriers develop mild-to-moderate spastic paraparesis in middle age or later. Adrenal function is usually normal.</Attribute>
                <XRef ID="NBK1315" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5758" />
                <XRef ID="5758" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000519128" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507942" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330513" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522268" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508448" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561876" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000559496" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500892" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520051" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512569" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000503088" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318975" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522163" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000503092" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522267" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521375" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301491</ID>
                <ID Source="BookShelf">NBK1315</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22071894</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="43" DB="Orphanet" />
              <XRef ID="C0162309" DB="MedGen" />
              <XRef ID="MONDO:0018544" DB="MONDO" />
              <XRef Type="MIM" ID="300100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3187" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1686" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Creatine deficiency, X-linked</ElementValue>
                <XRef ID="Creatine+Deficiency%2C+X-Linked/2001" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation , X-linked with seizures, short stature and midface hypoplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation , X-linked, with creatine transport deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked creatine transporter deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked creatine deficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SLC6A8-Related Creatine Transporter Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CREATINE TRANSPORTER DEFECT</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CEREBRAL CREATINE DEFICIENCY SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0006" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Creatine transporter deficiency</ElementValue>
                <XRef ID="MONDO:0010305" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CCDS1</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1608" />
                <XRef ID="1608" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The creatine deficiency disorders (CDDs), inborn errors of creatine metabolism and transport, comprise three disorders: the creatine biosynthesis disorders guanidinoacetate methyltransferase (GAMT) deficiency and L-arginine:glycine amidinotransferase (AGAT) deficiency; and creatine transporter (CRTR) deficiency. Developmental delay and cognitive dysfunction or intellectual disability and speech-language disorder are common to all three CDDs. Onset of clinical manifestations of GAMT deficiency (reported in ~130 individuals) is between ages three months and two years; in addition to developmental delays, the majority of individuals have epilepsy and develop a behavior disorder (e.g., hyperactivity, autism, or self-injurious behavior), and about 30% have movement disorder. AGAT deficiency has been reported in 16 individuals; none have had epilepsy or movement disorders. Clinical findings of CRTR deficiency in affected males (reported in ~130 individuals) in addition to developmental delays include epilepsy (variable seizure types and may be intractable) and behavior disorders (e.g., attention deficit and/or hyperactivity, autistic features, impulsivity, social anxiety), hypotonia, and (less commonly) a movement disorder. Poor weight gain with constipation and prolonged QTc on EKG have been reported. While mild-to-moderate intellectual disability is commonly observed up to age four years, the majority of adult males with CRTR deficiency have been reported to have severe intellectual disability. Females heterozygous for CRTR deficiency are typically either asymptomatic or have mild intellectual disability, although a more severe phenotype resembling the male phenotype has been reported.</Attribute>
                <XRef ID="NBK3794" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301745</ID>
                <ID Source="BookShelf">NBK3794</ID>
              </Citation>
              <XRef ID="52503" DB="Orphanet" />
              <XRef ID="C1845862" DB="MedGen" />
              <XRef ID="MONDO:0010305" DB="MONDO" />
              <XRef Type="MIM" ID="300352" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6541" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15903" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked Emery-Dreifuss muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0010680" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, tardive Emery-Dreifuss type, with contractures</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progressive muscle weakness and wasting initially in a humero-peroneal distribution that later extends to the scapular and pelvic girdle muscles; and cardiac involvement that may manifest as palpitations, presyncope and syncope, poor exercise tolerance, and congestive heart failure along with variable cardiac rhythm disturbances. Age of onset, severity, and progression of muscle and cardiac involvement demonstrate both inter- and intrafamilial variability. Clinical variability ranges from early onset with severe presentation in childhood to late onset with slow progression in adulthood. In general, joint contractures appear during the first two decades, followed by muscle weakness and wasting. Cardiac involvement usually occurs after the second decade and respiratory function may be impaired in some individuals.</Attribute>
                <XRef ID="NBK1436" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2102" />
                <XRef ID="2102" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301609</ID>
                <ID Source="BookShelf">NBK1436</ID>
              </Citation>
              <XRef ID="261" DB="Orphanet" />
              <XRef ID="98863" DB="Orphanet" />
              <XRef ID="C0751337" DB="MedGen" />
              <XRef ID="MONDO:0010680" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8154" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15989" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita</ElementValue>
                <XRef ID="Dyskeratosis+congenita/9566" DB="Genetic Alliance" />
                <XRef ID="MONDO:0015780" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS127550" DB="OMIM" />
                <XRef ID="74911008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10905" />
                <XRef ID="10905" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="1775" DB="Orphanet" />
              <XRef ID="C0265965" DB="MedGen" />
              <XRef ID="MONDO:0015780" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS127550" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="20865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia</ElementValue>
                <XRef ID="10DG0885" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                <XRef ID="HP:0001258" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0037772" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001258" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007062" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007124" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007216" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2927" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10795" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Class I glucose-6-phosphate dehydrogenase deficiency</ElementValue>
                <XRef ID="466026" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Favism, susceptibility to</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Anemia, nonspherocytic hemolytic, due to G6PD deficiency</ElementValue>
                <XRef ID="MONDO:0010480" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hemolytic anemia due to G6PD deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6520" />
                <XRef ID="6520" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="CPIC, 2014">
                <ID Source="PubMed">24787449</ID>
                <ID Source="pmc">4111801</ID>
              </Citation>
              <XRef ID="466026" DB="Orphanet" />
              <XRef ID="C2720289" DB="MedGen" />
              <XRef ID="MONDO:0010480" DB="MONDO" />
              <XRef Type="MIM" ID="300908" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3071" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="487" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">3-Methylglutaconic aciduria type 2</ElementValue>
                <XRef ID="Barth+Syndrome/744" DB="Genetic Alliance" />
                <XRef ID="297231002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Barth syndrome</ElementValue>
                <XRef ID="MONDO:0010543" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-methylglutaconicaciduria type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MGA type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardioskeletal myopathy with neutropenia and abnormal mitochondria</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MGCA2</ElementValue>
                <XRef Type="MIM" ID="302060" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BTHS</ElementValue>
                <XRef Type="MIM" ID="302060" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MGA2</ElementValue>
                <XRef Type="MIM" ID="302060" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Barth syndrome is characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, prepubertal growth delay, and distinctive facial gestalt (most evident in infancy); not all features may be present in a given affected male. Cardiomyopathy, which is almost always present before age five years, is typically dilated cardiomyopathy with or without endocardial fibroelastosis or left ventricular noncompaction; hypertrophic cardiomyopathy can also occur. Heart failure is a significant cause of morbidity and mortality; risk of arrhythmia and sudden death is increased. Neutropenia is most often associated with mouth ulcers, pneumonia, and sepsis. The nonprogressive myopathy predominantly affects the proximal muscles, and results in early motor delays. Prepubertal growth delay is followed by a postpubertal growth spurt with remarkable "catch-up" growth. Heterozygous females who have a normal karyotype are asymptomatic and have normal biochemical studies.</Attribute>
                <XRef ID="NBK247162" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5890" />
                <XRef ID="5890" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301486</ID>
                <ID Source="BookShelf">NBK1309</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299040</ID>
                <ID Source="BookShelf">NBK247162</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C5-OH Acylcarnitine, Organic Acidemias, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH-Elevated.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Organic Acidemias: Elevated C5-OH, 2022</CitationText>
              </Citation>
              <XRef ID="111" DB="Orphanet" />
              <XRef ID="C0574083" DB="MedGen" />
              <XRef ID="MONDO:0010543" DB="MONDO" />
              <XRef Type="MIM" ID="302060" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9834221" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000023.10:g.(?_152954030)_(154005142_?)del|MedGen:C0037772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005064037" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19846429</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11968085</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the L1CAM gene has been identified. Loss-of-function variants in L1CAM are known to be pathogenic (PMID: 19846429). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with X-linked hydrocephalus (PMID: 11968085). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152954030)_(154005142_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037772" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9834243" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000023.10:g.(?_152954030)_(154005142_?)del|MedGen:C0162309" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005064059" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11748843</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the ABCD1 gene has been identified. Loss-of-function variants in ABCD1 are known to be pathogenic (PMID: 11748843). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals affected with ABCD1-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152954030)_(154005142_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0162309" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9834387" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000023.10:g.(?_152954030)_(154005142_?)del|MedGen:C0265965" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005065477" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11379875</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18627054</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35384376</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the DKC1 gene has been identified. Loss-of-function variants in DKC1 are known to be pathogenic (PMID: 11379875, 18627054, 35384376). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals affected with DKC1-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152954030)_(154005142_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265965" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9834531" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000023.10:g.(?_152954030)_(154005142_?)del|MedGen:C0751337" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005065621" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24365856</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9384614</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10480214</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the EMD gene has been identified. Loss-of-function variants in EMD are known to be pathogenic (PMID: 24365856). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individuals with Emery‚ÄìDreifuss muscular dystrophy (EDMD) (PMID: 9384614, 10480214). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152954030)_(154005142_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751337" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9834498" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000023.10:g.(?_152954030)_(154005142_?)del|MedGen:C0574083" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005065588" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16427346</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22382802</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23409742</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19396829</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the TAZ gene has been identified. Loss-of-function variants in TAZ are known to be pathogenic (PMID: 16427346, 22382802, 23409742). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with Barth syndrome (PMID: 19396829). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152954030)_(154005142_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0574083" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9835354" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000023.10:g.(?_152954030)_(154005142_?)del|MedGen:C1845862" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005065709" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22281021</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16601897</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23660394</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24962355</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the SLC6A8 gene has been identified. Loss-of-function variants in SLC6A8 are known to be pathogenic (PMID: 22281021). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with clinical features of creatinine transporter deficiency (PMID: 16601897, 23660394, 24962355). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152954030)_(154005142_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845862" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9835787" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000023.10:g.(?_152954030)_(154005142_?)del|MedGen:C2720289" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005067378" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18177777</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with G6PD-related conditions. A gross deletion of the genomic region encompassing the full coding sequence of the G6PD gene has been identified. Loss-of-function variants in G6PD are known to be pathogenic (PMID: 18177777). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152954030)_(154005142_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2720289" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9834387" TraitType="Disease" MappingType="XRef" MappingValue="C0265965" MappingRef="MedGen">
        <MedGen CUI="C0265965" Name="Dyskeratosis congenita" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9835787" TraitType="Disease" MappingType="XRef" MappingValue="C2720289" MappingRef="MedGen">
        <MedGen CUI="C2720289" Name="Anemia, nonspherocytic hemolytic, due to G6PD deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9834498" TraitType="Disease" MappingType="XRef" MappingValue="C0574083" MappingRef="MedGen">
        <MedGen CUI="C0574083" Name="3-Methylglutaconic aciduria type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9835354" TraitType="Disease" MappingType="XRef" MappingValue="C1845862" MappingRef="MedGen">
        <MedGen CUI="C1845862" Name="Creatine transporter deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9834221" TraitType="Disease" MappingType="XRef" MappingValue="C0037772" MappingRef="MedGen">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9834531" TraitType="Disease" MappingType="XRef" MappingValue="C0751337" MappingRef="MedGen">
        <MedGen CUI="C0751337" Name="X-linked Emery-Dreifuss muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9834243" TraitType="Disease" MappingType="XRef" MappingValue="C0162309" MappingRef="MedGen">
        <MedGen CUI="C0162309" Name="Adrenoleukodystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

